The role of weight and enteric coating on aspirin response in cardiovascular patients

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 10, 2010, Pages 2323-2325

  Peace, A ^a   Mccall, M ^a   Tedesco, T ^a   Kenny, D ^b   Conroy, R M ^a   Foley, D ^b   Cox, D ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; THROMBOXANE B2;

BODY WEIGHT; CARDIOVASCULAR DISEASE; ENTERIC COATED TABLET; FOLLOW UP; HUMAN; LETTER; LOW DRUG DOSE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT EDUCATION; PRIORITY JOURNAL; TELEPHONE; TREATMENT DURATION; TREATMENT RESPONSE;

AGED; ASPIRIN; BODY WEIGHT; CARDIOLOGY; CARDIOVASCULAR DISEASES; HUMANS; MIDDLE AGED; PATIENT COMPLIANCE; SERUM; TABLETS, ENTERIC-COATED; THROMBOXANES; TIME FACTORS;

EID: 78649372270     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2010.03997.x     Document Type: Letter

References (15)

1. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 2002; 324: 71-86.
2. Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009; 373: 1849-60.
3. Hankey GJ, Eikelboom JW. Aspirin resistance. Lancet 2006; 367: 606-17.
4. Patrono C, Rocca B. Drug insight: aspirin resistance-fact or fashion? Nat Clin Pract Cardiovasc Med 2007; 4: 42-50.
5. Undas A, Brummel-Ziedins KE, Mann KG. Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions. Blood 2007; 109: 2285-92.
6. Cattaneo M. Laboratory detection of 'aspirin resistance': what test should we use (if any)? Eur Heart J 2007; 28: 1673-5.
7. Santilli F, Rocca B, De Cristofaro R, Lattanzio S, Pietrangelo L, Habib A, Pettinella C, Recchiuti A, Ferrante E, CiabattoniG, Davi{dotless}' G, Patrono C. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin 'resistance'. J Am Coll Cardiol 2009; 53: 667-77.
8. Weber AA, Przytulski B, Schanz A, Hohlfeld T, Schrör K. Towards a definition of aspirin resistance: a typological approach. Platelets 2002; 13: 37-40.
9. Krasopoulos G, Brister SJ, Beattie WS, Buchanan MR. Aspirin 'resistance' and risk of cardiovascularmorbidity: systematic review and meta-analysis. Br Med J 2008; 336: 195-8.
10. Sofi F, Marcucci R, Gori AM, Abbate R, Gensini GF. Residual platelet reactivity on aspirin therapy and recurrent cardiovascular events-a meta-analysis. Int J Cardiol 2008; 128: 166-71.
11. Cox D, Maree AO, Dooley M, Conroy R, Byrne MF, Fitzgerald DJ. Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers. Stroke 2006; 37: 2153-8.
12. Frelinger AL III, Furman MI, Linden MD, Li Y, Fox ML, Barnard MR, Michelson AD. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1-and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance. Circulation 2006; 113: 2888-96.
13. Lordkipanidze M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J 2007; 28: 1702-8.
14. Hovens MMC, Snoep JD, Eikenboom JCJ, van der Bom JG, Mertens BJA, Huisman MV. Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review. Am Heart J 2007; 153: 175-81.
15. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial.J Am Med Assoc 2006; 296: 2563-71.